無針注射 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の無針注射システムの市場規模は、2023年に124億9,000万米ドル、2030年までに276億5,000万米ドルに達し、2024年～2030年の予測期間にCAGRで14.16％の成長が見込まれます。無針注射システムの需要は、慢性疾患の有病率の上昇、針刺し損傷の拡大、自己注射器への要求の高まり、ワクチン接種プログラムの増加、製品開発における技術革新などの要因によって成長を示しています。

無針注射の市場力学

無針注射技術には、さまざまなモードを組み合わせ、圧力を利用して皮下に薬剤を投与し、皮下注射針を不要にするドラッグデリバリーシステムが含まれます。

無針注射市場の成長に影響を与える主な要因の1つは、患者や介護者の間で針刺し損傷が増加していることです。世界保健機関（WHO）（2019）が提供したデータによると、世界全体で年間3,500万人の医療従事者の間で200万人以上の職業的な針刺し損傷への曝露が発生しています。

2019年に発表された米国疾病予防管理センター（CDC）と欧州連合安全衛生庁（EU-Occupation Safety and Health Administration）のレポートによると、米国と欧州の病院の医療従事者の針刺し損傷の症例は、それぞれ年間に38万5,000件超と100万件超です。

針刺し損傷は、HIV、C型肝炎、B型肝炎を含む20種類以上の血液媒介感染症のリスクを増加させます。血液媒介病原体に感染するだけでなく、針刺し損傷は慢性疾患を引き起こし、心理的影響も引き起こす可能性があります。さらに、針刺しや鋭利な傷の管理には多大な費用がかかります。したがって、上記の要因のために、医療提供者、介護者、患者の安全性の見通しを向上させるだけでなく、薬剤や治療薬の安全な投与を可能にする無針注射システムへのニーズが市場で高まっています。

さらに、糖尿病などの慢性疾患の有病率の上昇も、無針注射市場の成長を助ける大きな要因の1つです。

IDF Diabetes Atlas（2023）の統計によると、2021年に5億3,700万人の成人が糖尿病を患っていました。この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。糖尿病を患う人々は、重要な治療法の1つとしてインスリンの定期的な投与を必要としています。糖尿病患者の多くは、毎日複数回のインスリン投与を必要とし、注射に伴う不安や痛みをしばしば経験しています。無針注射はインスリンを正確に自分で投与するための実質的に痛みのない方法を提供し、それによって患者の治療へのアドヒアランスとコンプライアンスを向上させます。

さらに、人口の大部分にCOVID-19ワクチンを提供することへの高い注目も、無針注射器に対する需要の増加につながっています。

したがって、慢性疾患の有病率の上昇、針刺し損傷の増加、より安全な自己注射器への需要の高まりが、無針注射市場の成長を促進すると予測されます。

しかし、トレーニングやデバイスのメンテナンスに対するより高い要件や、投与経路の制限、設計サイズのバリエーションにおける制限は、無針注射市場の成長の特定の抑制要因となる可能性があります。

無針注射市場のセグメント分析

無針注射器市場の用途セグメントでは、インスリンデリバリー用無針注射器が予測期間に大きなシェアを占めると予測されています。これは、世界中で糖尿病患者の有病率が上昇していることに起因しています。

糖尿病患者は1日に何度もインスリンを投与する必要がありますが、従来の注射器や注射針を使用してインスリンを投与する場合、患者にとっては大変な作業となります。これらのデバイスは、インスリンの微細な流れの生成をもたらすノズルオリフィスを介してインスリンの容易な投与を支援します。この流れは皮膚に浸透しやすいです。

当レポートでは、世界の無針注射市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 無針注射市場レポートのイントロダクション

第2章 無針注射市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 無針注射市場の主な要因の分析

• 無針注射市場の促進要因
  • 慢性疾患の有病率の上昇
  • 針刺し損傷の増加
  • ワクチン接種プログラムへの注目の高まり
  • 製品開発における技術革新
• 市場抑制要因と課題
  • デバイスの高い維持費とトレーニングの要件
  • 製品設計の制限
• 市場機会
  • 製品設計の強化
  • 新興市場をターゲットにした製品の発売

第5章 無針注射市場のポーターのファイブフォース分析

第6章 無針注射市場のレイアウト

• 製品タイプ別
  • 充填型
  • プレフィルド
• 技術別
  • ジェット式
  • バネ式
  • その他
• 使用性別
  • 再使用可能
  • 使い捨て
• 用途別
  • ワクチン
  • インスリン
  • 皮膚科
• エンドユーザー別
  • 病院
  • 診療所
  • 在宅ケア環境
• 地域別
  • 北米の無針注射の市場規模（2021年～2030年）
  • 欧州の無針注射の市場規模（2021年～2030年）
  • アジア太平洋の無針注射の市場規模（2021年～2030年）
  • その他の地域の無針注射の市場規模（2021年～2030年）

第7章 無針注射市場の企業と製品のプロファイル

• IntegriMedical LLC
• INJEX Pharma GmbH
• PharmaJet
• CrossJect
• European Pharma Group BV
• National Medical Products Inc
• Akra DermaJet
• Meika Medical CO.
• Basco India
• Mystic Pharmaceuticals Inc
• Technologies Medicales Internationales (MIT Canada) Inc.
• INOVIO Pharmaceuticals
• MADA MEDICAL PRODUCTS INC
• Portal Instruments
• D'Antonio Consultants International, Inc

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Needle-Free Injections Market in Global (2021-2030)
• Table 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
• Table 4: Needle-Free Injections Market in Global by Technology (2021-2030)
• Table 5: Needle-Free Injections Market in Global by Usability (2021-2030)
• Table 6: Needle-Free Injections Market in Global by Application (2021-2030)
• Table 7: Needle-Free Injections Market in Global by End-User (2021-2030)
• Table 8: Needle-Free Injections Market in Global by Geography (2021-2030)
• Table 9: Needle-Free Injections Market in North America (2021-2030)
• Table 10: Needle-Free Injections Market in the US (2021-2030)
• Table 11: Needle-Free Injections Market in Canada (2021-2030)
• Table 12: Needle-Free Injections Market in Mexico (2021-2030)
• Table 13: Needle-Free Injections Market in Europe (2021-2030)
• Table 14: Needle-Free Injections Market in France (2021-2030)
• Table 15: Needle-Free Injections Market in Germany (2021-2030)
• Table 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
• Table 17: Needle-Free Injections Market in Italy (2021-2030)
• Table 18: Needle-Free Injections Market in Spain (2021-2030)
• Table 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
• Table 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
• Table 21: Needle-Free Injections Market in China (2021-2030)
• Table 22: Needle-Free Injections Market in Japan (2021-2030)
• Table 23: Needle-Free Injections Market in India (2021-2030)
• Table 24: Needle-Free Injections Market in Australia (2021-2030)
• Table 25: Needle-Free Injections Market in South Korea (2021-2030)
• Table 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
• Table 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
• Table 28: Needle-Free Injections Market in the Middle East (2021-2030)
• Table 29: Needle-Free Injections Market in Africa (2021-2030)
• Table 30: Needle-Free Injections Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Needle-Free Injections Market in Global (2021-2030)
• Figure 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
• Figure 4: Needle-Free Injections Market in Global by Technology (2021-2030)
• Figure 5: Needle-Free Injections Market in Global by Usability (2021-2030)
• Figure 6: Needle-Free Injections Market in Global by Application (2021-2030)
• Figure 7: Needle-Free Injections Market in Global by End-User (2021-2030)
• Figure 8: Needle-Free Injections Market in Global by Geography (2021-2030)
• Figure 9: Needle-Free Injections Market in North America (2021-2030)
• Figure 10: Needle-Free Injections Market in the US (2021-2030)
• Figure 11: Needle-Free Injections Market in Canada (2021-2030)
• Figure 12: Needle-Free Injections Market in Mexico (2021-2030)
• Figure 13: Needle-Free Injections Market in Europe (2021-2030)
• Figure 14: Needle-Free Injections Market in France (2021-2030)
• Figure 15: Needle-Free Injections Market in Germany (2021-2030)
• Figure 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
• Figure 17: Needle-Free Injections Market in Italy (2021-2030)
• Figure 18: Needle-Free Injections Market in Spain (2021-2030)
• Figure 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
• Figure 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
• Figure 21: Needle-Free Injections Market in China (2021-2030)
• Figure 22: Needle-Free Injections Market in Japan (2021-2030)
• Figure 23: Needle-Free Injections Market in India (2021-2030)
• Figure 24: Needle-Free Injections Market in Australia (2021-2030)
• Figure 25: Needle-Free Injections Market in South Korea (2021-2030)
• Figure 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
• Figure 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
• Figure 28: Needle-Free Injections Market in the Middle East (2021-2030)
• Figure 29: Needle-Free Injections Market in Africa (2021-2030)
• Figure 30: Needle-Free Injections Market in South America (2021-2030)
• Figure 31: Market Drivers
• Figure 32: Market Barriers
• Figure 33: Marker Opportunities
• Figure 34: PORTER'S Five Force Analysis

Needle-Free Injections Market By Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to the increased risk of communicable infections as a result of needle injuries and needle phobia among the population.

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030. The demand for needle-free injection systems is witnessing growth due to the rising prevalence of chronic diseases, expanding number of needle-stick injuries, increasing requirement of self-injection devices, growing number of vaccination programs, and technological innovation in product development, among other factors.

Needle-Free Injections Market Dynamics:

Needle-free injection technology encompasses a wide spectrum of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

One of the major factors influencing the growth of the needle-free injection market is the rising number of needle stick injuries among patients and caregivers. As per the data provided by the World Health Organization (2019), globally more than two million occupational exposures to sharp injuries occur among 35 million healthcare workers annually.

According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-Occupation Safety and Health Administration) reports published in 2019, there are more than 385,000 and 1,000,000 needle stick injury cases annually among hospital healthcare workers in the United States and Europe, respectively.

Needle-stick injuries increase the risk of more than 20 types of blood-borne infectious diseases which include HIV, hepatitis C, and hepatitis B. In addition to becoming infected with blood-borne pathogens, needle stick injuries may result in chronic diseases and also cause psychological effects. Furthermore, the management of needle sticks and sharp injuries can be cost-intensive. Therefore, owing to the abovementioned factors, there is a growing need for needle-free injection systems in the market which allow for the safe administration of drugs and therapeutics as well improve the safety prospects of healthcare providers, caregivers, and patients.

Moreover, the rising prevalence of chronic diseases, such as diabetes is also one of the major factors aiding in the needle-free injections market growth.

As per statistics by the IDF Diabetes Atlas (2023), 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. People suffering from diabetes require regular administration of insulin as one of their key treatment regimens. Many diabetes patients require multiple daily doses of insulin and often experience anxiety and pain associated with injections. Needle-free injections offer a virtually painless method for the administration of insulin by themselves in a precise manner and thereby improving the adherence to treatment and compliance by patients.

Moreover, the increased focus on providing COVID-19 vaccines to the majority of the population has also resulted in the increased demand for needle-free injection devices as many pharmaceutical companies are entering into partnerships with needle-free injection manufacturers for expanding their customer reach.

Therefore, the rising prevalence of chronic diseases, and the increasing number of needle stick injuries, coupled with the growing demand for safer self-injection devices are projected to drive the needle-free injections market growth.

However, higher requirements for training and device maintenance, limitations in the route of administration, and limitations in the variation in the design size may prove to be certain restraints to the needle-free injection market growth.

Needle-Free Injections Market Segment Analysis:

Needle-Free Injections market by Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the application segment of the needle-free injections market, insulin delivery needle-free injections are expected to account for a significant share of the market during the forecast period. This can be attributed to the rising prevalence of diabetic population across the globe.

Diabetic patients require multiple doses of insulin in a day, which can be a daunting process for patients in case of using conventional syringes and needles for insulin administration. These devices aid in the easy administration of insulin through the nozzle orifice, which results in the generation of a fine stream of insulin. This stream then easily penetrates the skin.

Needle-free insulin injection systems offer the least resistant path for insulin administration, thereby facilitating the even spreading of the insulin in the subcutaneous layer.

Therefore, Needle-free injection devices for insulin administration are gaining popularity and are more extensively used than for other applications owing to the above-stated reason.

North America is expected to dominate the Overall Needle-Free Injections Market:

Among all the regions, North America is expected to account for the largest share of the needle-free injection market. The growing number of chronic diseases, more focus on vaccination programs, and access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the needle-free injections market over the forecast period.

As per the data published by National Center for Immunization and Respiratory Diseases (NCIRD) under the Centers for Disease Control and Prevention 2022, influenza was associated with 9 million illnesses, 4 million medical visits, and about 10,000 hospitalizations in the United States between 2021 and 2022.

Needle-free injection systems are used in the administration of different vaccines including influenza vaccines. CDC works each year to increase the number of people who receive a flu vaccine and eliminate barriers to vaccination. As flu vaccines are commonly administered in pediatric patients, these systems help in the easy administration of vaccines to children and people suffering from needle phobia, and other apprehensions. One example of this is the PharmaJet Stratis Needle-Free Injector which is the first needleless intramuscular Jet Injector approved by the US Food and Drug Administration for the delivery of an influenza vaccine.

Moreover, the well-established healthcare infrastructure in the country which can be supported by the high per capita healthcare expenditure in the country as well as the presence of a highly aware patient population further encourages people to opt for such devices.

Therefore, the above-mentioned factors are expected to propel the growth of the North America Needle-free injections market.

Needle-Free Injections Market Key Players:

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

Recent Developmental Activities in Needle-Free Injections Market:

In August 2022, PharmaJet and their partner Zydus Cadila announced the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world's first Plasmid DNA Vaccine for COVID-19. The vaccine- ZyCoV-D is exclusively administered by the deployment of the PharmaJet Tropis® Needle-free Injection System.

Key Takeaways from the Needle-Free Injections Market Report Study

Market size analysis for current needle-free injections market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global needle-free injections market

Various opportunities available for the other competitor in the needle-free injections market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current needle-free injections market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for needle-free injection market growth in the coming future?

Target Audience who can be benefited from this Needle-Free Injections Market Report Study

Needle-free injection systems products providers

Research organizations and consulting companies

Needle-free injection systems -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in needle-free injections market

Various End-Users who want to know more about the needle-free injections market and the latest technological developments in the needle-free injections market

Frequently Asked Questions for Needle-Free Injections Market:

1. What is a Needle Free Injection System?

Needle-free injection technology encompasses a wide spectrum of technology that includes a wide variety of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

2. What is the market for global needle-free injections?

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030.

3. What are the drivers for the global needle-free injections market?

The major drivers of the global needle-free injections market growth are the rising prevalence of chronic diseases, an increasing number of needle stack and sharp injuries, and a rising number of trauma cases, among other factors.

4. Who are the key players operating in the global needle-free injections market?

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

5. Which region has the highest share in the needle-free injections market?

North America is expected to dominate the overall needle-free injections market during the forecast period, 2024 to 2030. The accumulation of the highest revenue in the market can be ascribed to the rising prevalence of chronic diseases, increased focus on vaccination programs, improving the safety of healthcare providers, and increasing collaborations between key market players in the region.

Table of Contents

1. Needle-Free Injections Market Report Introduction

2. Needle-Free Injections Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Needle-Free Injections Market Key Factors Analysis

• 4.1. Needle-Free Injections Market Drivers
  • 4.1.1. Rising Prevalence of Chronic Diseases
  • 4.1.2. Rising Number of Needle Stick Injuries
  • 4.1.3. Growing Focus on Vaccination Programs
  • 4.1.4. Technological Innovation in Product Development
• 4.2. Market Restraints and Challenges
  • 4.2.1. High Device Maintenance and Requirement of Training
  • 4.2.2. Limitation with Product Design
• 4.3. Market Opportunities
  • 4.3.1. Enhancing Product Design
  • 4.3.2. Targeting Emerging Markets for Product Launches

5. Needle-Free Injections Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Needle-Free Injections Market Layout

• 6.1. By Product Type
  • 6.1.1. Fillable
  • 6.1.2. Prefilled
• 6.2. By Technology
  • 6.2.1. Jet-Based
  • 6.2.2. Spring-Based
  • 6.2.3. Others
• 6.3. By Usability
  • 6.3.1. Reusable
  • 6.3.2. Disposable
• 6.4. By Application
  • 6.4.1. Vaccine
  • 6.4.2. Insulin
  • 6.4.3. Dermatology
  • 6.4.4. Others
• 6.5. By End-User
  • 6.5.1. Hospitals
  • 6.5.2. Clinics
  • 6.5.3. Homecare Settings
  • 6.5.4. Others
• 6.6. By Geography
  • 6.6.1. North America Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.1.1. United States Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.1.2. Canada Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.1.3. Mexico Needle-Free Injections Market Size in USD million (2021-2030)
  • 6.6.2. Europe Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.1. France Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.2. Germany Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.3. United Kingdom Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.4. Italy Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.5. Spain Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2.6. Rest of Europe Needle-Free Injections Market Size in USD million (2021-2030)
  • 6.6.3. Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.1. China Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.2. Japan Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.3. India Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.4. Australia Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.5. South Korea Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3.6. Rest of Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
  • 6.6.4. Rest of the World (RoW) Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.4.1. Middle East Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.4.2. Africa Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.4.3. South America Needle-Free Injections Market Size in USD million (2021-2030)

7. Needle-Free Injections Market Company and Product Profiles

• 7.1. IntegriMedical LLC
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. INJEX Pharma GmbH
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. PharmaJet
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. CrossJect
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. European Pharma Group BV
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. National Medical Products Inc
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Akra DermaJet
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Meika Medical CO.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Basco India
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Mystic Pharmaceuticals Inc
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Technologies Medicales Internationales (MIT Canada) Inc.
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. INOVIO Pharmaceuticals
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. MADA MEDICAL PRODUCTS INC
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Portal Instruments
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. D'Antonio Consultants International, Inc
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us